LCID
Lucid Group, Inc.
LCID has slightly lower modeled downside risk, despite its lower overall score.
PRTS
CarParts.com, Inc.
PRTS has a slight edge over LCID overall, supported by stronger modeled upside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
PRTS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Strong |
PRTS's balance sheet is currently strong, and its revenue and profitability are stable, but its cash flow is under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
PRTS PE Valuation
PRTS has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
PRTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect PRTS's losses to shrink, with revenue growing.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over PRTS on earnings, with more consistent year-over-year improvement.
PRTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.56 | +$7.14 |
| Q2 2026 | -$3.93 | +$5.57 |
| Q1 2026 | -$5.80 | +$2.90 |
| Q4 2025 | -$8.20 | -$1.10 |
| Q3 2025 | -$9.70 | -$4.30 |
| Q2 2025 | -$9.50 | -$5.40 |
| Q1 2025 | -$8.70 | -$6.00 |
| Q4 2024 | -$7.10 | -$5.70 |
PRTS is still losing money, but far less than before: $2.56 per share over the past year, against $9.70 at its worst in late 2025.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over PRTS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
PRTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $129.3M | +1.2% |
| Q2 2026 | $135.6M | -11% |
| Q1 2026 | $132M | -10% |
| Q4 2025 | $120.4M | -9.8% |
| Q3 2025 | $127.8M | -12% |
| Q2 2025 | $151.9M | +5.3% |
| Q1 2025 | $147.4M | -11% |
| Q4 2024 | $133.5M | -15% |
PRTS's revenue has slid since its 2023 peak: $129M last quarter, up 1.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -2.9% | +4.9 points |
| Q2 2026 | -2.4% | +5.8 points |
| Q1 2026 | -2.3% | +8 points |
| Q4 2025 | -9.4% | +2.2 points |
| Q3 2025 | -7.9% | -1 points |
| Q2 2025 | -8.2% | -2.1 points |
| Q1 2025 | -10% | -6.4 points |
| Q4 2024 | -12% | -7.3 points |
PRTS has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
PRTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.7M | +$4.5M |
| Q2 2026 | $1.1M | +$28.9M |
| Q1 2026 | $5.2M | +52% |
| Q4 2025 | -$9.3M | -$8.6M |
| Q3 2025 | -$8.3M | -268% |
| Q2 2025 | -$27.9M | -$17.1M |
| Q1 2025 | $3.4M | +$7.2M |
| Q4 2024 | -$631K | +$11.7M |
PRTS has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has the edge over PRTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
PRTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.6% | +118K shares |
| 1 year | +32% | +1.9M shares |
| 3 years | +35% | +2M shares |
| 5 years | +47% | +2.5M shares |
| Available history | +109% | +4M shares |
PRTS has 8M diluted shares, up 32% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | $2.2M |
| Q3 2023 | $1.1M |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PRTS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | -7.5x | Net Cash |
| Q3 2023 | -8.4x | Net Cash |
| Q2 2023 | -8.6x | Net Cash |
| Q1 2023 | -3.7x | Net Cash |
| Q4 2022 | -1.3x | Net Cash |
| Q3 2022 | -0.8x | Net Cash |
| Q2 2022 | -1.6x | Net Cash |
| Q1 2022 | -3.2x | Net Cash |
PRTS has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
PRTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.1 | Neutral |
| Stochastic | 45.2 | Neutral |
PRTS's weekly RSI is 56 (neutral) and its Stochastic is 45 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
PRTS PE vs Consumer Cyclical Sector
PRTS has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
PRTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.17 | 3.1% above |
| 20 week MA | $7.36 | 14% above |
| 50 week MA | $6.88 | 22% above |
| 100 week MA | $7.74 | 8.8% above |
| 200 week MA | $18.7 | 55% below |
PRTS has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
PRTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.2 | $131.7 | +521% |
| 2021 | $131.7 | $119.6 | -9.2% |
| 2022 | $119.6 | $58.7 | -51% |
| 2023 | $58.7 | $31.6 | -46% |
| 2024 | $31.6 | $9.47 | -70% |
| 2025 | $9.47 | $4.50 | -52% |
| 2026 YTD | $4.50 | $8.42 | +87% |
PRTS has the edge over LCID on returns for 2026, with the stronger performance.